Making Reinvention Real with Gen AI

This report by Criticaleye Partner Accenture reflects on the lessons learned from the past year of Gen AI project delivery, offering actionable insights for leaders looking to implement and scale this transformative technology. This research reinforces the value of acting across all five imperatives that were identified in Accenture's 2024 Reinvention in the Age of Generative AI report.
 
Key takeaways include:

  • Organisations scaling Gen AI successfully are four-and-a-half times more likely to invest in agentic architecture - building the foundation for continuous reinvention
  • Three times more Gen AI budgets are spent on technology than on people
  • CEO sponsored Gen AI-enabled enterprise reinvention typically delivers two-and-a-half times more value




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
CEO Research Results 2025

This research, conducted at our CEO Retreat, subtitled When Leadership Goes Faster, provides a fascinating insight into the challenges and priorities for CEOs this year. Key findings from Criticaleye's CEO Resear...

Click here to download this insight
Building a High-performance C...

Delinian’s Chief People and Culture Officer, Kirsty Bashforth, speaks to Criticaleye’s Bridgette Hall about driving culture change across a high-growth, PE-backed portfolio. Kirsty shares how she’s bui...

Click here to download this insight
Destination Net Zero

The race to net zero is well underway, but how fast are companies really progressing? Criticaleye Partner Accenture’s Destination Net Zero report sheds light on this question. Drawing on data from the world&r...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 496




AlixPartners Experian Rolls-Royce London Stock Exchange Group Google Drax Group plc E.ON UK Palo Alto Networks Amazon UK IBM Consulting NATS Concentrix Workday Legal & General Investment Management FTSE Women Leaders Review LDC Hitachi Solutions Lightsource bp GlaxoSmithKline plc Redwood Bank Royal London Group Salesforce Accenture Eightfold AI